Large, real-world study compares modern treatment options for pulmonary embolism (REAL.PE)
2023-10-24
(Press-News.org) SAN FRANCISCO – A large, modern real-world analysis published today in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI), provides vital insights into the safety of novel therapies including ultrasound-assisted catheter-directed thrombolysis (USCDT) and mechanical thrombectomy (MT) that have been developed to address the increased morbidity and mortality of elevated risk pulmonary embolism (PE). Findings were presented today at TCT 2023.
Pulmonary embolism is a potentially life-threatening condition where a blood clot embolizes to the lungs, obstructing pulmonary blood flow. Traditionally, treatment options have included anticoagulant therapy and, in severe cases, surgical intervention. However, recent advancements in medical technology have introduced new minimally invasive procedures like ultrasound-assisted catheter-directed thrombolysis and mechanical thrombectomy.
Ultrasound-assisted catheter-directed thrombolysis is a procedure in which a catheter is threaded through the blood vessels to the site of the clot, and a thrombolytic drug is delivered directly into the thrombus. Ultrasound energy is applied during the infusion to assist in breaking down the clot and restoring blood flow. Mechanical thrombectomy involves using a device to physically remove the thrombus from the blood vessel.
In the REAL.PE study, all data from the Truveta, Inc. system were analyzed including 83,612,413 patients treated within 16 healthcare systems. This included analysis of 535,567 with PE. Every patient treated with USCDT (Boston Scientific) or MT (Inari Medical) for PE were identified. A primary analysis included every procedure performed within the system encompassing procedures performed from January 2009 – May 2023.A contemporary analysis was also performed on all procedures between January 2018 – May 2023 to allow for focus on procedures performed using up-to-date techniques and proceduralist skills. Bleeding was assessed via direct laboratory analysis and transfusion administration documentation. ISTH and BARC 3b definitions were also modelled. Multiple logistic regression analysis of major bleeding was performed, and in-hospital death and median length of stay was measured.
The results of the study were informative and important. The increasing use of advanced endovascular therapies was demonstrated and ultrasound-assisted catheter-directed thrombolysis emerged as the preferred approach due to its lower risk of complications particularly major bleeding. This finding was demonstrated in both cohorts and by all measures. An increased risk of intracranial hemorrhage with MT was also demonstrated in medical coding data documented within 7 days after the procedure. There were no statistically significant differences between the therapies in length of stay, readmission or inpatient mortality. The study also highlighted the importance of individual patient characteristics in determining the most suitable treatment modality.
For the primary analysis, 2,259 patients (N=1577 USCDT, N=682 MT) and for the contemporary analysis 1,798 patients (N=1,137 USCDT, N=661 MT) met criteria. Incidence of hemoglobin reduction (>2 and >5 g/dL) and transfusions received were significantly higher among MT- treated patients in both analyses, as was ISTH and BARC3b major bleeding (primary: ISTH MT 17.3% vs USCDT 12.4% p=0.002; BARC3b MT 15.4% vs USCDT 11.8% p=0.019) (contemporary: ISTH MT 17.2% vs USCDT 11.0% p =0.0002; BARC3B MT 15.4% vs USCDT 10.6% p=0.002). Regression analysis demonstrated that MT is uniquely associated with major bleeding. Median LOS, all-cause 30-day readmission and in-hospital mortality were similar between groups. Intracranial hemorrhage was more common with MT.
"This study is a significant step forward in our understanding of the treatment options available for pulmonary embolism," said Peter Monteleone, MD, FSCAI, lead researcher of the study. "The use of real-world data analytics like those used in REAL.PE holds the potential to revolutionize the way we are studying device effectiveness and safety and can transform our practice and protect our patients."
Session Details: Real World Experience of Contemporary Pulmonary Embolism Treatment (USCDT versus MT): Insights From Big Data Analytics (REAL-PE) Peter P. Monteleone; Endovascular Spotlight 3: Featured Clinical Science With Live Case; Tuesday, October 24, 2023 12:15 PM PDT
###
About SCAI
The Society for Cardiovascular Angiography & Interventions (SCAI) is a non-profit professional association with over 4,500 members representing interventional cardiologists and cardiac catheterization teams in the United States. SCAI promotes excellence in interventional cardiovascular medicine for both adults and children through education, representation, and the advancement of quality standards to enhance patient care. Follow @SCAI on Twitter for the latest heart health news.
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-10-24
The NSF-funded FABRIC project has completed installation of a unique network infrastructure connection, called the TeraCore—a ring spanning the continental U.S.—which boasts data transmission speeds of 1.2 Terabits per second (Tbps), or one trillion bits per second. FABRIC previously established preeminence with its cross-continental infrastructure, but the project has now hit another milestone as the only testbed capable of transmitting data at these speeds—the highest being twelve times faster than what was available ...
2023-10-24
Which sustainability goals do people in Germany find more important: Animal welfare? Or environmental protection? Human health is another one of these competing sustainability goals. A team of researchers from the Department of Agricultural and Food Market Research at the University of Bonn have now found that consumers surveyed in their study would rather pay more for salami with an “antibiotic-free” label than for salami with an “open barn” label that indicates that the product promotes animal welfare. The results have now been published in the journal “Q Open.”
The animal husbandry sector ...
2023-10-24
Following a national search, Paul Anderson, MD, PhD, has been named Chief Academic Officer for Mass General Brigham. Anderson, who has been serving in this role on an interim basis since January 1, oversees Mass General Brigham’s world-class research and teaching enterprise, which includes two academic medical centers — Mass General Hospital and Brigham and Women’s Hospital — and three specialty hospitals. Mass General Brigham is the largest hospital system-based research enterprise in the nation, with an annual ...
2023-10-24
Researchers have identified buried kimberlite, the rocky home of diamonds, by testing the DNA of microbes in the surface soil.
These ‘biological fingerprints’ can reveal what minerals are buried tens of metres below the earth’s surface without having to drill. The researchers believe it is the first use of modern DNA sequencing of microbial communities in the search for buried minerals.
The research published this week in Nature Communications Earth and Environment represents a new tool for mineral exploration, where a full toolbox could save prospectors time and a lot of money, says co-author Bianca Iulianella Phillips, a doctoral candidate at ...
2023-10-24
Adding crushed volcanic rock to cropland could play a key role in removing carbon from the air. In a field study, scientists at the University of California, Davis, and Cornell University found the technology stored carbon in the soil even during an extreme drought in California. The study was published in the journal Environmental Research Communications.
Rain captures carbon dioxide from the air as it falls and reacts with volcanic rock to lock up carbon. The process, called rock weathering, can take millions of years ...
2023-10-24
She has explored the brain’s secrets for more than 50 years, delving deep into the genes, proteins and cells that help govern our emotions and moods, and our responses to pleasure and pain.
And today, Huda Akil, Ph.D., received the nation’s highest scientific honor – the National Medal of Science -- for those contributions and their impact on humankind’s understanding of depression, anxiety, addiction and more.
Akil, a neuroscientist at the University of Michigan Medical School and Michigan Neuroscience Institute, and her fellow awardees were honored at the White House in a ceremony ...
2023-10-24
Arizona Health Opportunities Pathways to Excellence, a program of the University of Arizona Health Sciences Office of Equity, Diversity and Inclusion, received a $3.2 million grant from the U.S. Department of Health and Human Services to help students from disadvantaged backgrounds achieve their dreams of becoming health care professionals.
Arizona Health Opportunities Pathways to Excellence, or AZ-HOPE, is a collaboration between academic and community partners to support students’ educational endeavors and help them overcome barriers on the pathway ...
2023-10-24
Tuesday, October 24, 2023, Cleveland: Findings from a trial led by Cleveland Clinic show that patients with atrial fibrillation undergoing a transcatheter aortic valve replacement (TAVR) at the same time as a left atrial appendage occlusion (LAAO) procedure using the Watchman™ device had similar outcomes when compared to patients getting TAVR in addition to medical therapy or blood thinners.
Results from the “Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement — ...
2023-10-24
Like several immunosuppressive biologics, the JAK inhibitor upadacitinib is also approved for the treatment of Crohn's disease. Commissioned by the Federal Joint Committee (G-BA), the Institute for Quality and Efficiency in Health Care (IQWiG) has now investigated in an early benefit assessment whether the drug offers an added benefit versus the appropriate comparator therapy to patients with moderate to severe active Crohn's disease who have had an inadequate response, lost response or are intolerant to conventional therapy or a biologic agent.
Therefore, an added benefit is not proven due to a lack of suitable study data. The ...
2023-10-24
UNIVERSITY PARK, Pa. — While governments may take the lead in planning and financing climate change adaptation measures, such as incentivizing green infrastructure, individuals currently are most often the ones implementing actions to adapt to climate change, according to new research. The analysis, conducted by an international consortium of researchers from 20 institutions, including Penn State, in 12 countries, published in Nature Climate Change.
“The evidence suggests that individuals and households are the primary adaptation actors — the ones actually implementing ways to ...
LAST 30 PRESS RELEASES:
[Press-News.org] Large, real-world study compares modern treatment options for pulmonary embolism (REAL.PE)
